5-[2-[[4-(benzenesulfonyl)piperazin-1-yl]methyl]-8-morpholin-4-ylimidazo[1,2-a]pyrazin-6-yl]pyrimidin-2-amine
C25H29N9O3S — CID 46946047
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[2-[[4-(benzenesulfonyl)piperazin-1-yl]methyl]-8-morpholin-4-ylimidazo[1,2-a]pyrazin-6-yl]pyrimidin-2-amine
5-[2-[[4-(benzenesulfonyl)piperazin-1-yl]methyl]-8-morpholin-4-ylimidazo[1,2-a]pyrazin-6-yl]pyrimidin-2-amine (PubChem CID 46946047) has the molecular formula C25H29N9O3S and a molecular weight of 535.63 g/mol. Its IUPAC name is 5-[2-[[4-(benzenesulfonyl)piperazin-1-yl]methyl]-8-morpholin-4-ylimidazo[1,2-a]pyrazin-6-yl]pyrimidin-2-amine.
Molecular Properties
| Compound Name | 5-[2-[[4-(benzenesulfonyl)piperazin-1-yl]methyl]-8-morpholin-4-ylimidazo[1,2-a]pyrazin-6-yl]pyrimidin-2-amine |
|---|---|
| PubChem CID | 46946047 |
| Molecular Formula | C25H29N9O3S |
| Molecular Weight | 535.63 g/mol |
| Exact Mass | 535.21 |
| IUPAC Name | 5-[2-[[4-(benzenesulfonyl)piperazin-1-yl]methyl]-8-morpholin-4-ylimidazo[1,2-a]pyrazin-6-yl]pyrimidin-2-amine |
| SMILES | Nc1ncc(-c2cn3cc(CN4CCN(S(=O)(=O)c5ccccc5)CC4)nc3c(N3CCOCC3)n2)cn1 |
| InChI | InChI=1S/C25H29N9O3S/c26-25-27-14-19(15-28-25)22-18-33-17-20(29-23(33)24(30-22)32-10-12-37-13-11-32)16-31-6-8-34(9-7-31)38(35,36)21-4-2-1-3-5-21/h1-5,14-15,17-18H,6-13,16H2,(H2,26,27,28) |
| InChIKey | BBBDDBWDQRGYCG-UHFFFAOYSA-N |
| XLogP | 1.11 |
| TPSA | 135.08 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 38 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 535.63 |
| LogP ≤ 5 | 1.11 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 11 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 46946047 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.